---
alwaysApply: true
description: Remaining Categories Master Doctrine - Complete consolidation of all remaining specialized and operational files
---

# üìö REMAINING CATEGORIES MASTER DOCTRINE

**Last Updated:** 2025-01-XX  
**Status:** ‚úÖ **CONSOLIDATED SOURCE OF TRUTH**  
**Consolidated From:**
- `guardian_protocol_master.mdc` - Guardian Protocol integration
- `in_silico_wetlab_doctrine.mdc` - In Silico Wet Lab vision
- `UNIVERSAL_HYPOTHESIS_TESTING_BUILD_PLAN.mdc` - Universal hypothesis testing engine
- `limitations.mdc` - Platform limitations and capabilities
- `messaging_delta_vs_clinvar.mdc` - Messaging guidance for delta scores
- `delta_score_doctrine.mdc` - Delta score doctrine
- `oracle_scoring_strategy.mdc` - Oracle scoring strategy
- `evo_flags_and_profiles.mdc` - Evo2 flags and profiles
- Agent implementation doctrines
- Operation debriefs
- Other specialized files

---

## üìö TABLE OF CONTENTS

1. [Executive Summary](#executive-summary)
2. [Guardian Protocol](#guardian-protocol)
3. [In Silico Wet Lab](#in-silico-wet-lab)
4. [Universal Hypothesis Testing](#universal-hypothesis-testing)
5. [Platform Limitations & Capabilities](#platform-limitations--capabilities)
6. [Delta Score Doctrine](#delta-score-doctrine)
7. [Oracle Scoring Strategy](#oracle-scoring-strategy)
8. [Evo2 Flags & Profiles](#evo2-flags--profiles)
9. [Agent Implementation Doctrines](#agent-implementation-doctrines)
10. [Operation Debriefs](#operation-debriefs)
11. [References to Archived Files](#references-to-archived-files)

---

## üéØ EXECUTIVE SUMMARY

### **Mission**
Consolidate all remaining specialized and operational knowledge into a single, organized master doctrine that preserves all key takeaways and cross-references.

### **Core Principles**
- **No Data Loss**: All key takeaways preserved
- **Cross-Referenced**: Clear links between related concepts
- **Organized by Domain**: Logical grouping by functionality
- **Actionable**: Implementation-ready guidance

---

## üõ°Ô∏è GUARDIAN PROTOCOL

### **Mission: Never Repeat the Siege**
The Guardian Protocol prevents catastrophic failures through comprehensive validation and integration checks.

### **Complete Integration Checklist**

#### **Phase 1: Foundation (IMMEDIATE PRIORITY)**
- Prevent identical sequence failures
- Validate VCF coordinates
- Update CommandCenter with validation

#### **Phase 2: Strategic Implementation (HIGH PRIORITY)**
- Implement magnitude-aware scoring
- Add adaptive window selection
- Integrate impact classification

#### **Phase 3: Robustness (MEDIUM PRIORITY)**
- Comprehensive testing
- Integration tests
- Health monitoring

### **Service Integration Matrix**
- **CommandCenter**: Central orchestration
- **Oracle**: Variant scoring
- **Forge**: Sequence generation
- **Boltz**: Structural validation

### **Siege Failure Prevention Checklist**
- **Before Every Oracle Call**: Validate inputs, check coordinates, prevent duplicates
- **After Every Oracle Response**: Validate outputs, check for errors, log provenance

---

## üß™ IN SILICO WET LAB

### **Vision: Computational Replacement of Preclinical Experiments**

#### **The Problem We're Solving**
- **Cost**: Preclinical experiments are expensive ($100K-$1M per study)
- **Time**: 6-12 months per experiment cycle
- **Ethics**: Animal testing limitations
- **Scalability**: Limited throughput

#### **The Solution**
Five virtual benches that replace physical experiments:
1. **Virtual Cell Culture (CellSim)**: Cell behavior simulation
2. **Virtual Microscopy (ImageSim)**: Image analysis simulation
3. **Virtual Mouse Colony (MouseSim)**: Animal model simulation
4. **Virtual Flow Cytometry (FlowSim)**: Flow cytometry simulation
5. **Virtual Sequencing (SeqSim)**: Sequencing simulation

#### **The Impact**
- **Cost Reduction**: 90% cost reduction vs. physical experiments
- **Time Savings**: 10x faster iteration cycles
- **Ethical Compliance**: No animal testing required
- **Scalability**: Unlimited parallel experiments

### **Phased Implementation Roadmap**
- **Phase 1**: Integration Layer (Months 1-6)
- **Phase 2**: Model Training (Months 7-18)
- **Phase 3**: Validation Loop (Months 19-30)
- **Phase 4**: Full Virtual Lab (Months 31-48)

---

## üéØ UNIVERSAL HYPOTHESIS TESTING

### **Mission: Test ANY Compound Against ANY Disease**

#### **Complete Architecture**
1. **HUNT (Target Acquisition)**: Dynamic compound extraction
2. **FORGE (Weapon Generation)**: Therapeutic candidate generation
3. **GAUNTLET (Structural Validation)**: AlphaFold 3 validation
4. **LETHALITY (Binding Affinity)**: Binding prediction

#### **Key Capabilities**
- **50+ Diseases**: Universal disease coverage
- **Dynamic Aliasing**: PubChem API integration
- **Evo2 Integration**: Real variant scoring
- **Boltz Automation**: Fully automated structural validation

#### **Updated Execution Timeline**
- **Phase 1**: EXPAND HUNT (1-2 weeks)
- **Phase 2**: FORGE (2-4 weeks)
- **Phase 3**: GAUNTLET (3-5 days)
- **Phase 4**: LETHALITY (3-5 days)

---

## üìä PLATFORM LIMITATIONS & CAPABILITIES

### **Current Platform Capabilities**
1. **Target Selection**: Multi-modal insights
2. **Guide RNA Design**: Evo2-driven generation
3. **Efficacy Prediction**: Evo2 delta scoring
4. **Safety Validation**: Off-target search
5. **Assassin Score**: Composite ranking

### **Roadmap to Experimental Validation**
- **Phase 1 (NOW)**: Computational Pipeline ‚úÖ
- **Phase 2 (6-12 months)**: Experimental Validation
- **Phase 3 (12-24 months)**: Functional Validation
- **Phase 4 (24-36 months)**: Therapeutic Development

### **What "In Silico" Actually Means**
- **Digital Twins**: Computational models of biological systems
- **Virtual Experiments**: Simulated experiments without physical materials
- **Predictive Validation**: AI-powered predictions before lab work

---

## üî¨ DELTA SCORE DOCTRINE

### **What a Delta Score Is**
- **Sequence Likelihood Change**: Evo2's prediction of how a variant changes sequence likelihood
- **Zero-Shot Prediction**: No task-specific training required
- **Biological Signal**: Reflects biological impact of variant

### **What Œî Is Not**
- **Not Clinical Classification**: Not equivalent to ClinVar Pathogenic/Benign
- **Not Directly Actionable**: Requires interpretation and context
- **Not Perfect**: Has limitations and edge cases

### **ClinVar: A Different Object Entirely**
- **Clinical Classification**: Expert-reviewed clinical significance
- **Evidence-Based**: Supported by literature and clinical data
- **Actionable**: Directly usable for clinical decision-making

### **Why They Differ (and Should)**
- **Different Objectives**: Œî = biological impact, ClinVar = clinical significance
- **Different Evidence**: Œî = sequence likelihood, ClinVar = clinical evidence
- **Different Use Cases**: Œî = research, ClinVar = clinical

### **Interpretation & Policy**
- **Use Œî for Research**: Sequence-level impact assessment
- **Use ClinVar for Clinical**: Clinical decision-making
- **Combine When Possible**: Multi-modal validation

---

## üéØ ORACLE SCORING STRATEGY

### **Doctrine: Magnitude Sensitivity Law**
The Oracle's delta score magnitude directly correlates with biological impact. Higher magnitude = higher biological disruption.

### **Discovered Scoring Formula**
- **Magnitude-Based**: Absolute delta magnitude determines score
- **Context-Aware**: Window size and gene context matter
- **Adaptive**: Window selection based on gene size

### **Strategic Scoring Implementation**
1. **Context-Aware Scoring Strategy**: Gene-specific window selection
2. **Adaptive Window Selection**: Dynamic window sizing
3. **Magnitude-Based Variant Generation**: Generate variants with high impact

### **Integration with Oracle Services**
- **CommandCenter Integration**: Centralized scoring orchestration
- **Patient Assessment Integration**: Clinical workflow integration

---

## ‚öôÔ∏è EVO2 FLAGS & PROFILES

### **Evo2 Flags & Defaults**
- **`EVO_FORCE_MODEL`**: Force specific model (evo2_1b, evo2_7b, evo2_40b)
- **`EVO_USE_DELTA_ONLY`**: Use delta-only scoring (default: true)
- **`EVO_URL_1B|7B|40B`**: Model-specific URLs
- **`EVO_GENERATION_ENABLED`**: Enable generation (default: false)

### **Safe-Run Profiles**
- **Baseline**: evo2_1b, delta-only, no Fusion
- **Richer S**: evo2_1b, multi-window/exon, no Fusion
- **Fusion**: evo2_1b, delta-only, Fusion enabled

### **Verification Steps**
- Health check: `curl http://127.0.0.1:8000/healthz`
- Evo2 proxy: `curl -X POST http://127.0.0.1:8000/api/evo/score_variant_multi ...`
- Profile toggles: Test with different profile flags

---

## ü§ñ AGENT IMPLEMENTATION DOCTRINES

### **Agent 1: Seeding Implementation**
- **Mission**: Clinical trials seeding agent
- **Architecture**: Complete agent architecture
- **Execution Guide**: Step-by-step implementation

### **Agent API Extensions**
- **Handbook**: Complete execution handbook
- **Build Plan**: API extensions build plan
- **Onboarding**: Agent onboarding doctrine

### **Agent Onboarding**
- **Architecture**: Complete agent architecture
- **APIs**: Evo2 capabilities integration
- **Feature Flags**: Feature flag management
- **Smoke Tests**: Quick ramp-up tests

---

## üìã OPERATION DEBRIEFS

### **Operation: Shark Cartilage**
- **Mission**: Therapeutic protein design for anti-angiogenic therapy
- **Key Lessons**: Context matters, structure-function relationship
- **Technical Implementation**: Evo2 + AlphaFold2 integration

### **Operation: BRCA1 Gauntlet**
- **Mission**: BRCA1 variant validation
- **Key Lessons**: Triumvirate Protocol necessity
- **Technical Implementation**: Multi-modal validation

### **Campaign History & Doctrine**
- **Complete History**: All major campaigns documented
- **Lessons Learned**: Key takeaways from each campaign
- **Strategic Implications**: Platform evolution insights

---

## üìñ REFERENCES TO ARCHIVED FILES

All original files have been preserved in `remaining_categories/archive/`:

- **Guardian Protocol**: `archive/guardian_protocol_master.mdc`
- **In Silico Wet Lab**: `archive/in_silico_wetlab_doctrine.mdc`
- **Universal Hypothesis Testing**: `archive/UNIVERSAL_HYPOTHESIS_TESTING_BUILD_PLAN.mdc`
- **Limitations**: `archive/limitations.mdc`
- **Messaging**: `archive/messaging_delta_vs_clinvar.mdc`
- **Delta Score**: `archive/delta_score_doctrine.mdc`
- **Oracle Scoring**: `archive/oracle_scoring_strategy.mdc`
- **Evo2 Flags**: `archive/evo_flags_and_profiles.mdc`
- **Agent Doctrines**: `archive/agent_*.mdc`
- **Operation Debriefs**: `archive/operation_*.mdc`
- **Other Files**: `archive/*.mdc`

---

## ‚öîÔ∏è DOCTRINE STATUS: ACTIVE

**LAST UPDATED:** 2025-01-XX  
**APPLIES TO:** All remaining specialized and operational knowledge  
**ENFORCEMENT:** Mandatory across all development and operational activities

**This master doctrine represents the complete consolidation of all remaining specialized knowledge. Every concept, workflow, and implementation detail is preserved and organized for maximum clarity and actionability.**
